Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...

Patients with chronic lymphocytic leukemia (CLL) had significantly lower monocyte-to-lymphocyte ratio values compared with ...

The humanized IgG4 monoclonal antibody was first approved for myasthenia gravis in the US in 2023, with approvals in Japan ...

In advanced non–small cell lung cancer (NSCLC), discontinuing immunotherapy after 2 years can maintain durable responses ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

A qualitative study found strong support for primary care provider–nephrologist comanagement of chronic kidney disease (CKD), ...

Making treatment for non–small cell lung cancer (NSCLC) accessible to a wide range of the population can help to improve ...

Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like ...

US adults who were displaced and never returned home due to a natural disaster had the highest odds of developing depression or anxiety.

A new study finds that drugmakers’ use of overlapping patents delayed generic entry for 4 top-selling drugs, driving billions in excess spending.

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.